Skip to main content
[Preprint]. 2022 Apr 4:2021.11.10.21266139. Originally published 2021 Nov 11. [Version 3] doi: 10.1101/2021.11.10.21266139

Figure 4:

Figure 4:

Daily new infections assuming no antiviral treatment (Baseline) or assuming coverage of 10–100% of eligible symptomatic individuals in A) Kenya, B) Mexico, C) United States and D) Belgium. Here, we assumed an epidemic wave with parameters similar to those of the Omicron epidemic wave (transmissibility, vaccine effectiveness, and vaccination coverage). For each location, each column represents a different value of AVT (25, 50, 75 or 100% reduction in viral load).